[A word of warning about economic evaluations]

Gac Sanit. 2004 Nov-Dec;18(6):486; author reply 487-8. doi: 10.1016/s0213-9111(04)72038-5.
[Article in Spanish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Infective Agents / economics*
  • Anti-Infective Agents / therapeutic use
  • Costs and Cost Analysis
  • Health Care Costs
  • Humans
  • Protein C / economics*
  • Protein C / therapeutic use
  • Recombinant Proteins / economics*
  • Recombinant Proteins / therapeutic use
  • Sepsis / drug therapy
  • Sepsis / economics*

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated